Skip to main content
Clinical Trials/NCT05782647
NCT05782647
Completed
Not Applicable

Feasibility of Blood Pressure Measurement With a Wearable (Watch-type) Monitor in Patients With Syncope

Istituto Auxologico Italiano1 site in 1 country81 target enrollmentMay 25, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Syncope, Vasovagal
Sponsor
Istituto Auxologico Italiano
Enrollment
81
Locations
1
Primary Endpoint
BP during event during tilt testing
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The main purpose of this study is to assess the reliability of a new patient's self-administered wearable watch-type BP monitor in detecting episodes of hypotensive (pre)syncope. Secondary aim regards the estimation of feasibility of this tool.

Detailed Description

Background While ECG monitoring is a reliable and established method that allows to document bradycardia in a substantial proportion of patients affected by cardioinhibitory reflex syncope, the documentation of a transient hypotension is only seldom achieved in patients affected by hypotensive syncope. Conventional ambulatory blood pressure (BP) monitoring (ABPM) has important limitations due to the short period of monitoring (usually 24-48 hours) and the intermittent nature of BP measurements (usually every 15-20 min). The main purpose of this study is to assess the reliability of a new patient's self-administered wearable watch-type BP monitor in detecting episodes of hypotensive (pre)syncope. Secondary aim regards the estimation of feasibility of this tool. Method The study is a prospective intrapatient comparison during tilt testing between BP measured by mean of a wearable watch-type BP monitor (Omron HeartGuide 6410T, Omron Healthcare, Kyoto, Japan) and by mean of the standard methods for continuous finger BP monitoring (Finometer®, Finapres Medical Systems, Enchede, The Netherlands, and Task Force® monitor, CNSystem, Graz, Austria), based on the photoplethysmographic volume clamp method . Study design BP values observed during tilt testing baseline and at the time of impeding syncope will be measured by mean of the HeartGuide device and will be compared with the standard of reference of BP. BP will be recorded at rest at baseline, shortly after upright in tilting position (at stabilization), at the time of occurrence of impeding syncope (presyncope) or, alternatively at the time of maximum hypotensive effect, if syncope will not occur, and finally in the recovery period at the end of the test after returning in supine position.

Registry
clinicaltrials.gov
Start Date
May 25, 2021
End Date
June 30, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Consecutive patients,
  • \>18 years of age, referred for tilt testing because affected by suspected reflex syncope

Exclusion Criteria

  • Arrhythmias or the inability of HeartGuide to measure BP supine at rest.

Outcomes

Primary Outcomes

BP during event during tilt testing

Time Frame: 2 hours

Difference between baseline (rest) BP and BP at the presyncopal event ("Delta BP slope") during tilt testing with HeartGuide and with control

Secondary Outcomes

  • Compliance(2 hours)

Study Sites (1)

Loading locations...

Similar Trials